Clinical and laboratory testing for trichomonas vaginalis infection

Abstract

Trichomonas vaginalis infection is highly prevalent in the United States and worldwide. Traditional clinical diagnostic methods fail to identify more than half of these infections that, if left untreated, can result in adverse pregnancy outcomes and an exacerbated risk of both acquisition and transmission of HIV.Womenbear a disproportionate amount of the burden of these infections, and testing among populations at risk for this disease should be provided. Molecular technologies have expanded our capacity for laboratorybased detection of infection and can be used on samples already being collected for chlamydia/gonorrhea screening.